🇺🇸 FDA
Company

ACADIA

ACADIA PHARMACEUTICALS INC

ACAD pharma USA

Quick answer

ACADIA is a pharma company (ACAD) headquartered in SAN DIEGO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

ACP-204

Lewy Body Dementia Psychosis

Phase 3 · small_molecule · active

2 trials project

ACP-204

Alzheimer's Disease Psychosis

Phase 3 · small_molecule · active

2 trials project

Carbetocin

Hyperphagia in Prader-Willi Syndrome

Phase 3 · small_molecule · active

2 trials project

Pimavanserin

Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Phase 3 · small_molecule · completed

2 trials project

Pimavanserin

Adjunctive Treatment of Major Depressive Disorder

Phase 3 · small_molecule · terminated

3 trials project

Pimavanserin

Schizophrenia

Phase 3 · small_molecule · completed

4 trials project

Pimavanserin

Irritability Associated With Autism Spectrum Disorder

Phase 3 · small_molecule · completed

2 trials project

Pimavanserin tartrate (ACP-103)

Parkinson's Disease Psychosis

Phase 3 · small_molecule · completed

4 trials project

Placebo

Dementia-related Psychosis

Phase 3 · small_molecule · completed

1 trials project

Trofinetide

Rett Syndrome

Phase 3 · small_molecule · completed

4 trials project

pimavanserin tartrate

Parkinson's Disease Psychosis

Phase 3 · small_molecule · completed

1 trials project

ACP-044 Dose A

Acute Postoperative Pain

Phase 2 · small_molecule · completed

1 trials project

ACP-044 Dose A

Osteoarthritis Pain

Phase 2 · small_molecule · terminated

1 trials project

ACP-103

Hallucinations

Phase 2 · small_molecule · completed

1 trials project

ACP-103

Schizophrenia

Phase 2 · small_molecule · completed

1 trials project

ACP-104

Schizophrenia

Phase 2 · small_molecule · completed

2 trials project

ACP-211

Major Depressive Disorder (MDD)

Phase 2 · small_molecule · active

1 trials project

Active drug: pimavanserin 17mg (2 strength tablets)

Parkinson Disease

Phase 2 · small_molecule · completed

1 trials project

Pimavanserin

Parkinson's Disease

Phase 2 · small_molecule · terminated

1 trials project

Pimavanserin

Agitation and Aggression in Alzheimer's Disease

Phase 2 · small_molecule · completed

1 trials project

Pimavanserin

Treatment of Depression in Adults With Parkinson's Disease (PD)

Phase 2 · small_molecule · completed

1 trials project

Pimavanserin 34 mg

Agitation and Aggression in Alzheimer's Disease

Phase 2 · small_molecule · terminated

1 trials project

Pimavanserin 34 mg

Intermittent Explosive Disorder

Phase 2 · small_molecule · active

1 trials project

Pimavanserin 34 milligrams (MG) [Nuplazid]

Schizophrenia

Phase 2 · small_molecule · terminated

1 trials

Drugs (2)

drug

pimavanserin tartrate

NUPLAZID

 drug

trofinetide

DAYBUE

Patents (8)

patent

US 11844764

Agitation process for preparing a carbetocin drug product

Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11827600

Crystalline forms of trofinetide

Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11464768

Pimavanserin alone or in combination for use in the treatment of Alzheimer's dis

Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11452721

Formulations of pimavanserin

Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11191757

Combination of pimavanserin and cytochrome P450 modulators

Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11161826

Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent

Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11135211

Pimavanserin for treating impulse control disorder

Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11091473

Compounds for pain treatment, compositions comprising same, and methods of using

Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)